Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Shares Outstanding (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Shares Outstanding for 7 consecutive years, with $8.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 172.25% to $8.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $8.6 million, a 172.25% increase, with the full-year FY2024 number at $8.5 million, down 99.25% from a year prior.
  • Shares Outstanding was $8.6 million for Q3 2025 at SANUWAVE Health, roughly flat from $8.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $1.2 billion in Q2 2024 to a low of $1.5 million in Q2 2023.
  • A 3-year average of $55.1 million and a median of $3.2 million in 2024 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: soared 78772.47% in 2024, then crashed 99.27% in 2025.
  • SANUWAVE Health's Shares Outstanding stood at $3.0 million in 2023, then surged by 180.9% to $8.5 million in 2024, then grew by 0.38% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Shares Outstanding are $8.6 million (Q3 2025), $8.6 million (Q2 2025), and $8.5 million (Q1 2025).